Metraipolis › archive › dc_a5e3405732fc

Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral… — Europe PMC PMID:41514629

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41514629
DOI
10.3390/cancers18010120
License (as archived)
solo-consultazione
Archived
2026-11-07T07:52:23.142Z
SHA-256 of the archived text
37900089d22056a05cc9e7c151becbb7795f91e57a17c3133db30f442194df25
Stable URL of this page
https://metraipolis.com/documento/dc_a5e3405732fc

How to cite

Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral… — Europe PMC PMID:41514629 — Europe PMC (en), https://europepmc.org/article/MED/41514629 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5e3405732fc (Metraipolis archive dc_a5e3405732fc, sha256 37900089d22056a05cc9e7c151becbb7795f91e57a17c3133db30f442194df25)
BibTeX
@misc{dca5e3405732fc,
  title = {Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral… — Europe PMC PMID:41514629},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41514629},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5e3405732fc; sha256 37900089d22056a05cc9e7c151becbb7795f91e57a17c3133db30f442194df25},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514629. Agents can read the archived copy with the MCP tool read_document.